A Message from our Founder
“Never doubt that a small group of thoughtful, committed citizens can change the world. Indeed, it is the only [...]
April is Esophageal Cancer Awareness Month!
ECAN is proud to have started Esophageal Cancer Awareness Month in 2009. We've been thrilled ever since by all [...]
Congress Slashes by 57% Program Funding Esophageal Cancer Research
As a shutdown deadline loomed, members of the US House and Senate voted to pass a budget plan crafted [...]
Learn About Inherited Gene Mutations & the Link to Esophageal Adenocarcinoma
Join us as Dr. Amitabh Chak and Dr. Kishore Guda of Case Western Reserve School of Medicine in Cleveland [...]
Major Insurer Provides Coverage for PreCancer Screening
A First Step for Lucid, perhaps a Giant Leap for Patients at Risk for Esophageal Cancer! In what could [...]
Art Journaling for Patients & Caregivers
ECAN is offering Esophageal Cancer Patients & Caregivers a special course in Art Journaling. Art journaling is a [...]
Learn about the Latest Therapy Approved by the FDA for Gastroesophageal Cancer Patients
A new type of therapy has been approved by the FDA for patients with Gastroesophageal Adenocarcinoma. Learn more. On [...]
More than 75% of Oncologists in some Communities are Not Ordering Biomarker Testing per Guidelines
Needed Biomarker Testing Not Happening for Patients with Advanced Gastroesophageal Cancer in Many Community Practices. In a Project with [...]
Find out about the Latest in Advancements for Esophageal Cancer Treatment
ECAN will host a free webinar on Tuesday, March 4, 2025 at 2:15 pm Eastern time to explore the [...]
FDA approves New Therapy Aimed at a New Target in Esophageal Cancer at the GE Junction
The Food and Drug Administration (FDA) has approved Zolbetuximab (Vyloy) as a first-line treatment for patients with advanced HER2* [...]